Evoke Pharma Inc (EVOK)
0.436
-0.01
(-2.57%)
USD |
NASDAQ |
Apr 25, 16:00
0.434
0.00 (0.00%)
Pre-Market: 20:00
Evoke Pharma Free Cash Flow (Quarterly): -1.106M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.106M |
| September 30, 2023 | -1.042M |
| June 30, 2023 | -1.206M |
| March 31, 2023 | -1.631M |
| December 31, 2022 | -2.506M |
| September 30, 2022 | -1.101M |
| June 30, 2022 | -1.374M |
| March 31, 2022 | -1.615M |
| December 31, 2021 | -1.997M |
| September 30, 2021 | -5.892M |
| June 30, 2021 | -1.510M |
| March 31, 2021 | -2.953M |
| December 31, 2020 | -1.712M |
| September 30, 2020 | -1.810M |
| June 30, 2020 | -1.556M |
| March 31, 2020 | -1.552M |
| December 31, 2019 | -1.148M |
| September 30, 2019 | -1.059M |
| June 30, 2019 | -1.628M |
| March 31, 2019 | -1.927M |
| December 31, 2018 | -1.249M |
| September 30, 2018 | -1.150M |
| June 30, 2018 | -1.762M |
| March 31, 2018 | -2.818M |
| Date | Value |
|---|---|
| December 31, 2017 | -2.734M |
| September 30, 2017 | -2.200M |
| June 30, 2017 | -2.096M |
| March 31, 2017 | -1.687M |
| December 31, 2016 | -1.370M |
| September 30, 2016 | -2.418M |
| June 30, 2016 | -2.230M |
| March 31, 2016 | -2.690M |
| December 31, 2015 | -2.452M |
| September 30, 2015 | -2.504M |
| June 30, 2015 | -2.544M |
| March 31, 2015 | -2.995M |
| December 31, 2014 | -2.521M |
| September 30, 2014 | -3.912M |
| June 30, 2014 | -3.068M |
| March 31, 2014 | -2.001M |
| December 31, 2013 | -1.889M |
| September 30, 2013 | -0.2747M |
| June 30, 2013 | -0.4298M |
| March 31, 2013 | -0.4465M |
| December 31, 2012 | -0.6528M |
| September 30, 2012 | -0.3015M |
| June 30, 2012 | -0.348M |
| March 31, 2012 | -0.4476M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-5.892M
Minimum
Sep 2021
-1.042M
Maximum
Sep 2023
-1.810M
Average
-1.556M
Median
Jun 2020
Free Cash Flow (Quarterly) Benchmarks
| Eton Pharmaceuticals Inc | 0.387M |
| NovaBay Pharmaceuticals Inc | -0.316M |
| Palatin Technologies Inc | -10.51M |
| iBio Inc | -4.706M |
| Theriva Biologics Inc | -6.597M |